HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Four novel mutations of the coproporphyrinogen III oxidase gene.

Abstract
Here we report the characterization of four novel mutations and a previously described one of the coproporphyrinogen III oxidase (CPO) gene in five Italian patients affected by Hereditary Coproporphyria (HCP). Three of the novel genetic variants are missense mutations (p.Gly242Cys; p.Leu398Pro; p.Ser245Phe) and one is a frameshift mutation (p.Gly188TrpfsX45).
AuthorsC Aurizi, G Lupia Palmieri, L Barbieri, A Macrì, F Sorge, G Usai, G Biolcati
JournalCellular and molecular biology (Noisy-le-Grand, France) (Cell Mol Biol (Noisy-le-grand)) Vol. 55 Issue 1 Pg. 15-8 (Feb 16 2009) ISSN: 1165-158X [Electronic] France
PMID19267996 (Publication Type: Journal Article)
Chemical References
  • Coproporphyrinogen Oxidase
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Coproporphyria, Hereditary (genetics)
  • Coproporphyrinogen Oxidase (genetics)
  • DNA Mutational Analysis
  • Female
  • Frameshift Mutation (genetics)
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Mutation (genetics)
  • Mutation, Missense (genetics)
  • Pedigree
  • Polymerase Chain Reaction
  • Sequence Analysis, DNA
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: